On April 22, 2011
Glaxo Lawyer Says Disclosing Illegal Activity Would Be “Misleading” to the FDA
A former lawyer for GlaxoSmithKline has all but admitted she concealed evidence from the FDA that the company was illegally promoting the antidepressant Wellbutrin as a diet pill.
No tags for this post.
0 Comments